LA-419

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLA-419
Drug Alias NameLA-419AB-171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsNot applicable
Therapy Area/IndicationsPeripheral Arterial DiseaseMyocardial IschemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLacer Sa
China Registration ClassN/A

Develop Information

Active CompaniesLacer Sa
Inactive CompaniesN/A
Active IndicationsPeripheral Arterial DiseaseMyocardial IschemiaHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A